Sort   by:  
 Page size 
UnknownQuantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.
Not available
S-EPMC10495436 | biostudies-literature
UnknownSARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Not available
S-EPMC9762734 | biostudies-literature
UnknownT cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination.
Not available
S-EPMC12065855 | biostudies-literature
UnknownVitamin D insufficiency in COVID-19 and influenza A, and critical illness survivors: a cross-sectional study.
Not available
S-EPMC8728359 | biostudies-literature
UnknownDevelopment and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study.
Not available
S-EPMC7832571 | biostudies-literature
UnknownNon-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study.
Not available
S-EPMC8104907 | biostudies-literature
UnknownGenetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk.
Not available
S-EPMC3142887 | biostudies-literature
UnknownProcalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission.
Not available
S-EPMC9070482 | biostudies-literature
UnknownDetection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020.
Not available
S-EPMC7651873 | biostudies-literature
UnknownDistinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.
Not available
S-EPMC9043502 | biostudies-literature
Sort   by:  
 Page size